October 1, 2020

The Niche

Knoepfler lab stem cell blog

datacrat

5 min read

Professor Steven Pinker of Harvard has been making the case recently that when it comes to novel biotechnologies such as CRISPR-Cas9 that bioethics should just get out of the way. Further, he has argued that we do not need a moratorium on clinical use of CRISPR-Cas9 for human genetic modification. In fact, he says that such a moratorium would be harmful. I think he’s wrong about that. I’m not a bioethicist so rather than talk primarily about his views on bioethics, I’m going to …Read More